Key result
Subcutaneous ICD implantation beneath an axillary-femoral bypass graft achieves safe and successful defibrillation post-sternectomy.
Why the study?
S-ICDs reduce lead-related complications and provide an alternative to transvenous ICDs when venous access is difficult or infection risk is high.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Demonstrates the technical feasibility and safety of implanting an S-ICD by tunneling the lead beneath an axillary-femoral bypass graft and lateral to a sternectomy with omental flap reconstruction in a patient lacking superior venous access.
Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are clinically superior to conventional transvenous ICDs (TV-ICDs) in terms of reducing lead-related complications.1,2 Moreover, S-ICDs are an effective alternative to TV-ICDs in patients with difficulty in obtaining venous access and a high risk of infection. Here we present a case of a secondary prophylactic S-ICD implantation that was passed under an axillary femoral (A-F) bypass vessel and a successful subcutaneous lead placement in a patient after a sternectomy.
No takes yet. Share an insight, caveat, or question.
Sugawara et al. (2022) conducted a case report in Sustained monomorphic ventricular tachycardia with history of axillary bifemoral bypass and sternectomy (n=1). Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation was evaluated on Successful S-ICD lead placement and defibrillation threshold testing without acute complications. Subcutaneous ICD implantation under an axillary-femoral bypass graft achieved successful defibrillation with a 65 J shock (46 Ω impedance) without complications in a post-sternectomy patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: